Vantaggiato, L.; Frisenda, M.; Shaba, E.; Splendore, C.; Sciarra, B.; Bini, L.; Sciarra, A.; Landi, C.
Proteomic Profiling of Non-Muscle Invasive Bladder Cancer Reveals Stage-Specific Molecular Signatures and Prognostic Biomarkers. Proteomes 2025, 13, 65.
https://doi.org/10.3390/proteomes13040065
AMA Style
Vantaggiato L, Frisenda M, Shaba E, Splendore C, Sciarra B, Bini L, Sciarra A, Landi C.
Proteomic Profiling of Non-Muscle Invasive Bladder Cancer Reveals Stage-Specific Molecular Signatures and Prognostic Biomarkers. Proteomes. 2025; 13(4):65.
https://doi.org/10.3390/proteomes13040065
Chicago/Turabian Style
Vantaggiato, Lorenza, Marco Frisenda, Enxhi Shaba, Chiara Splendore, Beatrice Sciarra, Luca Bini, Alessandro Sciarra, and Claudia Landi.
2025. "Proteomic Profiling of Non-Muscle Invasive Bladder Cancer Reveals Stage-Specific Molecular Signatures and Prognostic Biomarkers" Proteomes 13, no. 4: 65.
https://doi.org/10.3390/proteomes13040065
APA Style
Vantaggiato, L., Frisenda, M., Shaba, E., Splendore, C., Sciarra, B., Bini, L., Sciarra, A., & Landi, C.
(2025). Proteomic Profiling of Non-Muscle Invasive Bladder Cancer Reveals Stage-Specific Molecular Signatures and Prognostic Biomarkers. Proteomes, 13(4), 65.
https://doi.org/10.3390/proteomes13040065
